Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q4YP
|
|||
Former ID |
DCL000648
|
|||
Drug Name |
TAK-100
|
|||
Synonyms |
CHEMBL1672127
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Discontinued in Phase 1 | [1] | |
Company |
Takeda
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H30N2O2
|
|||
Canonical SMILES |
CCC1=C(C(=C(C(=N1)CC(C)(C)C)CN)C2=CC=C(C=C2)C)CC(=O)O
|
|||
InChI |
1S/C22H30N2O2/c1-6-18-16(11-20(25)26)21(15-9-7-14(2)8-10-15)17(13-23)19(24-18)12-22(3,4)5/h7-10H,6,11-13,23H2,1-5H3,(H,25,26)
|
|||
InChIKey |
HQVOROHHYWZJLD-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dipeptidyl peptidase 4 (DPP-4) | Target Info | Inhibitor | [2] |
KEGG Pathway | Protein digestion and absorption | |||
NetPath Pathway | IL2 Signaling Pathway | |||
TGF_beta_Receptor Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800028364) | |||
REF 2 | Clinical pipeline report, company report or official report of Takeda (2009). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.